BioSpace News Archive

Consolidated Results of Operations, As Reported and As Adjusted - Three-month periods ended March 31, 2020 and 2019

Orally bioavailable small molecule CD73 inhibitors reverse immunosuppression by blocking adenosine production

AMAG Pharmaceuticals, Inc. announced that its first quarter 2020 financial results will be released on Monday, May 11, 2020 before the U.S. financial markets open.

American Skin Association announced that Dr. Mark Lebwohl, a leading expert in dermatology, has become a member of its Board of Directors.

Avadel Pharmaceuticals plc, a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced that it is commencing an underwritten public offering of $100 million in ordinary shares, in the form of American Depositary Shares.

Amcor plc will announce its year to date results for the nine months ended 31 March 2020 after the US market closes at 4.00 pm US Eastern Daylight Time on Monday 11 May 2020 / 6.00 am Australian Eastern Standard Time on Tuesday 12 May 2020.

Extendicare Inc. provided the following statement related to the ongoing COVID-19 pandemic..

Cipher Pharmaceuticals Inc. announced it will release its Q1 2020 financial results on Thursday, May 7, 2020. The company will hold a conference call on Friday, May 8, 2020 to discuss the results.

- Company’s goal to initiate clinical trial in patients in 2020 - Innovative therapy candidate uses next generation mesenchymal stem cells (MSCs) derived from a master cell bank of induced pluripotent stem cells (iPSCs)

On March 5, 2020, RRS Medical announced the acquisition of Quest Health Information Management Solutions, a St. Louis-based healthcare information management company